PGF and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, placenta-derived growth factor (PlGF) is increased in CML, stimulating angiogenesis in the bone marrow and promoting CML cell proliferation, metabolism and disease progression, while the inhibition of PlGF synergizes with imatinib [160].